Juan C. Pari-Salas, School of Human Medicine, Anatomy Department, Universidad Católica de Santa María, Arequipa; Department of Oncology and Radiotherapy, Radiotherapy Service, Hospital Goyeneche, Arequipa; Perú
Alberto E. Gonzáles-Ccoscco, Department of Oncology and Radiotherapy, Radiotherapy Service, Hospital Goyeneche, Arequipa; Department of Radiotherapy, Instituto Regional de Enfermedades Neoplásicas del Centro, Huancayo, Junín; School of Health Sciences, Radiation Physics Department, Professional Academic School of Medical Technology, Universidad Peruana Los Andes, Huancayo, Junín. Perú
Digna C. Santos-Flores, Department of Oncology and Radiotherapy, Radiotherapy Service, Hospital Goyeneche, Arequipa, Perú
Verónica del Rosario Quispe-Charaja, Department of Oncology and Radiotherapy, Radiotherapy Service, Hospital Goyeneche, Arequipa, Perú
Albert Bedregal-Cruz, Department of Oncology and Radiotherapy, Radiotherapy Service, Hospital Goyeneche, Arequipa, Perú

Brachytherapy has undeniable role in cervical cancer treatment. As image-guided brachytherapy can be done with computed tomography (CT). We report our first CT-guided brachytherapy case. A 62-year patient with IIIC1 stage received chemotherapy and chemoradiotherapy, 50.4 Gy/28 fractions with central protection (CP) last six fractions. Four brachytherapy applications were done. There were issues in reporting the dose, because CP, dose to 90% of high risk clinical target volume was 85.9 Gy, and organ at risk doses were within the constraints. At 3 months, the patient is alive and well, with mild abdominal pain. It is feasible, with few resources, to advance from 2D to 3D CT-guided brachytherapy.